183 related articles for article (PubMed ID: 19064983)
1. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
Anagnostou VK; Syrigos KN; Bepler G; Homer RJ; Rimm DL
J Clin Oncol; 2009 Jan; 27(2):271-8. PubMed ID: 19064983
[TBL] [Abstract][Full Text] [Related]
2. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL
Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151
[TBL] [Abstract][Full Text] [Related]
3. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
[TBL] [Abstract][Full Text] [Related]
4. Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung.
Barlési F; Pinot D; Legoffic A; Doddoli C; Chetaille B; Torre JP; Astoul P
Br J Cancer; 2005 Aug; 93(4):450-2. PubMed ID: 16052216
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Martins SJ; Takagaki TY; Silva AG; Gallo CP; Silva FB; Capelozzi VL
Lung Cancer; 2009 Apr; 64(1):105-9. PubMed ID: 18801593
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.
Fujiwara S; Nawa A; Nakanishi T; Shimoyama Y; Kajiyama H; Shibata K; Ino K; Nakamura S; Kikkawa F; Yatabe Y
Hum Pathol; 2010 Apr; 41(4):560-5. PubMed ID: 20004952
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis.
Li X; Wan L; Shen H; Geng J; Nie J; Wang G; Jia N; Dai M; Bai X
J Thorac Oncol; 2012 Jan; 7(1):76-84. PubMed ID: 22011671
[TBL] [Abstract][Full Text] [Related]
8. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
9. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
10. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
11. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung.
Semba S; Iwaya K; Matsubayashi J; Serizawa H; Kataba H; Hirano T; Kato H; Matsuoka T; Mukai K
Clin Cancer Res; 2006 Apr; 12(8):2449-54. PubMed ID: 16638851
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma.
Narahashi T; Niki T; Wang T; Goto A; Matsubara D; Funata N; Fukayama M
Histopathology; 2006 Oct; 49(4):349-57. PubMed ID: 16978197
[TBL] [Abstract][Full Text] [Related]
14. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
[TBL] [Abstract][Full Text] [Related]
15. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
16. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
17. Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas.
Zhang Y; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Li H; Shen L; Yu Y; Sun Y; Chen H
J Thorac Oncol; 2015 Oct; 10(10):1444-50. PubMed ID: 26200450
[TBL] [Abstract][Full Text] [Related]
18. Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma.
Kikuchi R; Sonobe M; Kobayashi M; Ishikawa M; Kitamura J; Nakayama E; Menju T; Miyahara R; Huang CL; Date H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S412-20. PubMed ID: 21732141
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of OCT4 expression in adenocarcinoma of the lung.
Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q
Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
